Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dysbiosis: early-phase trial registry
8 of 14 indexed Dysbiosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 8 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Dysbiosis: 14 US clinical trials tracked, 8 recruiting.
Dysbiosis is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Florida State University, running 3 of these trials.
Enrollment posture brief
Registry condition dysbiosis
OPEN 8 | RECR 57% | LATE 0 | EARLY 1 | RANK #1230 | SPON 3
Volume-matched condition peers
Nearest open-share peer: ACL (57% recruiting · 7 trials)
Dysbiosis lists 8 open slots (57% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dysbiosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dysbiosis is recruiting above its size-band peers.
8 of 14 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Dysbiosis research.
Florida State University accounts for 3 of 14 trials (21.4%). 11 distinct sponsors appear on at least one study for this condition label.
-
Most Dysbiosis trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 14 trials that report a genuine target (sentinel values excluded). 10 of those (71.4%) plan for fewer than 100 participants.
-
Dysbiosis research is mostly interventional.
11 interventional and 3 observational studies make up this index (78.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Vanderbilt University Medical Center
NCT05288790
Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention
Shirish S Barve
NCT06005298
Effect of Peanut Butter on Gut and Metabolic Health
Florida State University
NCT06916936
Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health
Florida State University
NCT06914375
Personalized GI Motility Responses to Diet
University of Illinois at Urbana-Champaign
NCT06386471
A Study of Healthy Microbiome, Healthy Mind
Mayo Clinic
NCT06020703
Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women
University of California, Davis
NCT06544954
Effect of Watermelon on Gut and Cardiometabolic Health
Florida State University
NCT06588218
My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)
Persephone Biosciences
NCT05472688
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
University of Pennsylvania
NCT05622721
Almonds to Improve Gut Health and Decrease Inflammation
Oregon State University
NCT05790564
Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components
Ohio State University
NCT05318183
Gut-level Antiinflammatory Activities of Green Tea in Metabolic Syndrome
Ohio State University
NCT03973996
A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US
Emory University
NCT03043300
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Dysbiosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dysbiosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dysbiosis page
14 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Dysbiosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Florida State University sponsors the most Dysbiosis trials on record, review their full trial history before evaluating a specific study. See Florida State University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dysbiosis condition card totals 14 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.